| Followers | 236 |
| Posts | 10817 |
| Boards Moderated | 0 |
| Alias Born | 07/17/2006 |
Tuesday, February 23, 2021 7:55:34 AM
Vacation....
Re: BNGO and the tech sell off...
Not my words...but what Yahoo is oozing out is that tech is passe' and that everyone should be buying Treasuries...Ie "Back to the seventies"...Not going to happen...The government is too far..(much too far) in debt and can't continue to give handouts to the minorities...can't raise bond yields. Fed on later today. The market will get the message..no radical raise..
Tech is our market. And should be. FCB. Faster Cheaper Better...BNGO is a winner..It's a winner not only because it will save lives and improve improve the quality of life by correcting conditions in the Autism sector and improve micro sectors such as gender ambiguity ..But when fused with sibling technologies such as Illumina, and Crisper will address serious medical conditions before they become serious...and this has the potential to pertain to every process that we now call diseases. This will have amazing economic consequences...simply because it allows for early diagnosis and correction of conditions before they becomes expensive problems...
We already test for phenylketonuria. Its just a BNGO DNA will identify susceptibility for diabetes, cancer, neurological and cardio vascular and even conditions like sociopathy...and we are on the verge of correcting these misprints in the genetic code book. The economic gains are going to be staggering...Could be the end of all hospitals except those who treat trauma....
":>) JL
Re: BNGO and the tech sell off...
Not my words...but what Yahoo is oozing out is that tech is passe' and that everyone should be buying Treasuries...Ie "Back to the seventies"...Not going to happen...The government is too far..(much too far) in debt and can't continue to give handouts to the minorities...can't raise bond yields. Fed on later today. The market will get the message..no radical raise..
Tech is our market. And should be. FCB. Faster Cheaper Better...BNGO is a winner..It's a winner not only because it will save lives and improve improve the quality of life by correcting conditions in the Autism sector and improve micro sectors such as gender ambiguity ..But when fused with sibling technologies such as Illumina, and Crisper will address serious medical conditions before they become serious...and this has the potential to pertain to every process that we now call diseases. This will have amazing economic consequences...simply because it allows for early diagnosis and correction of conditions before they becomes expensive problems...
We already test for phenylketonuria. Its just a BNGO DNA will identify susceptibility for diabetes, cancer, neurological and cardio vascular and even conditions like sociopathy...and we are on the verge of correcting these misprints in the genetic code book. The economic gains are going to be staggering...Could be the end of all hospitals except those who treat trauma....
":>) JL
Recent BNGO News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/28/2026 12:00:17 PM
- Bionano Announces Full Retirement of Outstanding Senior Secured Convertible Debentures • GlobeNewswire Inc. • 05/28/2026 12:00:00 PM
- Bionano Announces Largest OGM Study of T-Cell Acute Lymphoblastic Leukemia • GlobeNewswire Inc. • 05/26/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 10:16:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 10:15:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2026 08:29:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2026 08:09:36 PM
- Bionano Reports First Quarter 2026 Results and Provides a Business Update • GlobeNewswire Inc. • 05/13/2026 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2026 08:03:04 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 05/08/2026 08:02:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2026 08:30:53 PM
- Bionano Announces Leadership Transition • GlobeNewswire Inc. • 05/06/2026 08:30:00 PM
- Bionano Announces a 56% Increase in Publications Describing the Utility of OGM in Rare Diseases in Q1 2026 vs Q1 2025 • GlobeNewswire Inc. • 05/05/2026 12:00:00 PM
- Bionano to Report First Quarter 2026 Financial Results and Host a Conference Call Webcast on May 13, 2026 • GlobeNewswire Inc. • 04/29/2026 08:05:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/02/2026 08:06:01 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/02/2026 08:04:43 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/02/2026 08:02:51 PM
- Bionano Announces Publication from Johns Hopkins and MD Anderson Showing that OGM can Outperform Traditional Methods in Analysis of Multiple Myeloma • GlobeNewswire Inc. • 04/02/2026 12:00:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/25/2026 08:28:43 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/23/2026 08:08:58 PM
- Bionano Reports Fourth Quarter and Full-Year 2025 Results and Provides Revenue Outlook for 2026 • GlobeNewswire Inc. • 03/23/2026 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/23/2026 08:04:52 PM
- Bionano to Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call Webcast on March 23, 2026 • GlobeNewswire Inc. • 03/09/2026 08:05:00 PM
- Bionano Symposium 2026 Concluded with 9 Speakers Describing the Breadth of Bionano Solutions and Their Potential for Use on a Large Scale • GlobeNewswire Inc. • 02/27/2026 01:00:00 PM
- 10 Presentations on Day 3 of Bionano Symposium 2026 Showcase OGM’s Utility in Unraveling the Complex Puzzles of Constitutional Genetic Disorders • GlobeNewswire Inc. • 02/26/2026 01:00:00 PM
